Stock Events

Stock Events

Sera Prognostics 

$2.07
9
+$0.04+1.97% Wednesday 20:00

Statistics

Day High
2.2
Day Low
1.99
52W High
4.09
52W Low
1.37
Volume
23,167
Avg. Volume
62,454
Mkt Cap
77.89M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.25
-0.22
-0.19
-0.16
Expected EPS
-0.166667
Actual EPS
N/A

Financials

-43,763.64%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
154,000Revenue
-67.4MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SERA. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Natera
NTRA
Mkt Cap27.3B
Natera offers prenatal screening tests, directly competing with Sera Prognostics' offerings in the maternal and fetal health space.
Illumina
ILMN
Mkt Cap18.99B
Illumina provides genomic sequencing solutions that are foundational to developing prenatal tests, making them a key competitor in the broader market for genetic testing related to pregnancy.
Quest Diagnostics
DGX
Mkt Cap19.57B
Quest Diagnostics offers a range of maternal and fetal health tests, including genetic testing, competing with Sera Prognostics in the clinical lab testing market.
Labcorp
LH
Mkt Cap21.08B
LabCorp provides comprehensive clinical laboratory services, including tests for maternal and fetal health, directly competing with Sera Prognostics.
Myriad Genetics
MYGN
Mkt Cap748.08M
Myriad Genetics offers genetic testing and precision medicine, including prenatal tests, competing in the same space as Sera Prognostics.
Fulgent Genetics
FLGT
Mkt Cap687.17M
Fulgent Genetics offers genetic testing for various conditions, including reproductive health, making it a competitor in the prenatal testing market.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific provides a wide range of scientific research and diagnostic tools, including those used in prenatal testing, making them a competitor in the broader diagnostics market.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories offers products and services for life science research and clinical diagnostics, including prenatal testing, competing in the diagnostics and research market.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health focuses on cancer diagnostics but its advanced genomic sequencing capabilities make it a potential competitor in the broader market for genetic testing, including prenatal diagnostics.

About

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Show more...
CEO
Ms. Evguenia Lindgardt M.B.A.
Employees
63
Country
US
ISIN
US81749D1072

Listings

XNAS
US
SERA
BOATS
BOATS
SERA.BOATS

0 Comments

Share your thoughts

FAQ

What is Sera Prognostics stock price today?▼
The current price of SERA is $2.07 USD — it has increased by +1.97% in the past 24 hours. Watch Sera Prognostics stock price performance more closely on the chart.
What is Sera Prognostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sera Prognostics stocks are traded under the ticker SERA.
Is Sera Prognostics stock price growing?▼
SERA stock has risen by +4.02% compared to the previous week, the month change is a -7.17% fall, over the last year Sera Prognostics has showed a -40% decrease.
What is Sera Prognostics market cap?▼
Today Sera Prognostics has the market capitalization of 77.89M
When is the next Sera Prognostics earnings date?▼
Sera Prognostics is going to release the next earnings report on May 13, 2026.
What were Sera Prognostics earnings last quarter?▼
SERA earnings for the last quarter are -0.16 USD per share, whereas the estimation was -0.19 USD resulting in a +15.33% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Sera Prognostics revenue for the last year?▼
Sera Prognostics revenue for the last year amounts to 154,000 USD.
What is Sera Prognostics net income for the last year?▼
SERA net income for the last year is -67.4M USD.
How many employees does Sera Prognostics have?▼
As of April 02, 2026, the company has 63 employees.
In which sector is Sera Prognostics located?▼
Sera Prognostics operates in the Health Care sector.
When did Sera Prognostics complete a stock split?▼
Sera Prognostics has not had any recent stock splits.
Where is Sera Prognostics headquartered?▼
Sera Prognostics is headquartered in Salt Lake City, US.